11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biopsy core features are poor predictors of adverse pathology in men with Grade Group 1 prostate cancer
    Journal Article

    Audenet, F.; Vertosick, E. A.; Fine, S. W.; Sjoberg, D. D.; Vickers, A. J.; Reuter, V. E.; Eastham, J. A.; Scardino, P. T.; Touijer, K. A.
    Journal of Urology (2018)

    Fulltext@MSK | Save
  • Exercise implementation in oncology: One size does not fit all
    Journal Article

    Adams, S. C.; Iyengar, N. M.; Scott, J. M.; Jones, L. W.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: A pilot randomized controlled trial
    Journal Article

    Gehring, K.; Kloek, C. J. J.; Aaronson, N. K.; Janssen, K. W.; Jones, L. W.; Sitskoorn, M. M.; Stuiver, M. M.
    Clinical Rehabilitation (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    Journal Article

    Levine, J. M.; Whitton, J. A.; Ginsberg, J. P.; Green, D. M.; Leisenring, W. M.; Stovall, M.; Robison, L. L.; Armstrong, G. T.; Sklar, C. A.
    Cancer (2018)

    Fulltext@MSK | Save
  • Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Koch, R.; Porcu, P.; Oki, Y.; Moskowitz, A.; Perez, M.; Myskowski, P.; Officer, A.; Jaffe, J. D.; Morrow, S. N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
    Journal Article

    Flinn, I. W.; O’Brien, S.; Kahl, B.; Patel, M.; Oki, Y.; Foss, F. F.; Porcu, P.; Jones, J.; Burger, J. A.; Jain, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of atopy on risk of glioma: A Mendelian randomisation study
    Journal Article

    Disney-Hogg, L.; Cornish, A. J.; Sud, A.; Law, P. J.; Kinnersley, B.; Jacobs, D. I.; Ostrom, Q. T.; Labreche, K.; Eckel-Passow, J. E.; Armstrong, G. N.; more...
    BMC Medicine (2018)

    Fulltext@MSK | Save